癌治療のための薬剤投与:ストキャスティックモデル予測制御の視点
Andrés Hernández-Rivera1, Pablo Velarde2, Ascensión Zafra-Cabeza1
1Department of System and Automation Engineering, University of Seville, Spain.
Journal of theoretical biology
|September 2, 2025
まとめ
この研究は,がん治療のための新しい非線形ストキャスティックモデル予測制御 (SMPC) を提示しています. 先進的な方法は,腫瘍の成長の不確実性と治療の副作用を考慮することによって,薬剤の投与を効果的に管理します.
科学分野:
- 制御理論
- コンピュータ生物学
- 腫瘍学
背景:
- ストキャスティック・モデル・プレディクティブ・コントロール (SMPC) は,固有の不確実性を持つシステムに対する強力な意思決定の枠組みです.
- 腫瘍の動態を管理し 治療の毒性を最小限に抑えるには 精密な制御戦略が必要です
研究 の 目的:
- パーソナライズされたがん治療に合わせた非線形ストキャスティックモデル・プレディクティブ・コントロール (SMPC) の策定を開発し評価する.
- 腫瘍の成長と治療による副作用のストキャスティックな性質を制御の枠組みの中で対処する.
主な方法:
- 非線形SMPCアルゴリズムは,がん治療のダイナミクスをモデル化するために策定された.
- モデルにはストキャスティックな腫瘍の成長,非線形システムの動態,および潜在的な治療副作用が組み込まれました.
- 制御の性能を評価するために1年間のシミュレーションが行われました.
主要な成果:
- 提案された非線形SMPC戦略は,薬剤の投与量を制御する上で有意な効果を示した.
- この方法は,腫瘍の成長と治療への反応に関連した不確実性をうまく導きました.
- シミュレーションは,適応的投与によって治療結果の改善の可能性を示した.
結論:
- 非線形SMPCは複雑な生物学的不確実性を管理することによって,がん治療の最適化のための有望なアプローチを提供します.
- この制御戦略により パーソナライズされ より効果的ながん治療法が生まれます
- 提案されたSMPCフレームワークの臨床実施と検証をさらに検討する必要があります.
関連する概念動画
02:50Combination Therapies and Personalized Medicine
5.1K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
5.1K
01:24Rational Dosage Regimen: Maintenance Dose and Loading Dose
4.4K
A rational dosage regimen considers a drug's pharmacokinetics, including its absorption, distribution, metabolism, and elimination from the body. By understanding these factors, the appropriate dosage can be determined, and the dosing schedule can be designed to achieve and maintain the desired therapeutic effect while minimizing adverse effects.
In most cases, drugs are administered repetitively or infused continuously to maintain a steady-state concentration in the body. At a steady...
In most cases, drugs are administered repetitively or infused continuously to maintain a steady-state concentration in the body. At a steady...
4.4K
01:15Drug Dosage Regimen: Overview
3.8K
A drug dosage regimen describes the specific instructions and schedule for administering a drug to a patient. It considers factors such as drug dosage, frequency, route of administration, and duration of treatment. Designing an appropriate dosage regimen for a patient aims to achieve a target drug concentration at the site of action.
Typically, the starting dose and dosing interval are guided by the manufacturer's recommendations based on clinical trials conducted during and after drug...
Typically, the starting dose and dosing interval are guided by the manufacturer's recommendations based on clinical trials conducted during and after drug...
3.8K
01:01Dosage Regimen: Fixed Dose
2.0K
Fixed-dose regimens are a common approach to administer drugs to achieve and maintain desired levels of the drug in the body. In this dosing strategy, a specific amount of medication is given at regular intervals, often multiple times a day, to ensure a consistent drug concentration in the bloodstream.
Fixed-dose regimens can be used for various routes of administration, including intravenous (IV) injections and oral medications. For IV administration, a predetermined amount of the drug is...
Fixed-dose regimens can be used for various routes of administration, including intravenous (IV) injections and oral medications. For IV administration, a predetermined amount of the drug is...
2.0K
01:19Nonlinear Pharmacokinetics: Overview
544
Nonlinear or dose-dependent pharmacokinetics is a phenomenon that occurs when the pharmacokinetic parameters of certain drugs deviate from linear pharmacokinetics at higher doses. These drugs do not follow the expected first-order kinetics, where the rate of drug elimination is directly proportional to the drug concentration. Instead, they exhibit a nonlinear relationship, which can be attributed to several factors.
Nonlinearity can arise due to the saturation of plasma protein-binding or...
Nonlinearity can arise due to the saturation of plasma protein-binding or...
544
01:06Model Approaches for Pharmacokinetic Data: Distributed Parameter Models
126
Pharmacokinetic models are mathematical constructs that represent and predict the time course of drug concentrations in the body, providing meaningful pharmacokinetic parameters. These models are categorized into compartment, physiological, and distributed parameter models.
The distributed parameter models are specifically designed to account for variations and differences in some drug classes. This model is particularly useful for assessing regional concentrations of anticancer or...
The distributed parameter models are specifically designed to account for variations and differences in some drug classes. This model is particularly useful for assessing regional concentrations of anticancer or...
126